Muslims continue protest against demolition of mosque in China

Agencies
August 11, 2018

Chinese state media has defended the planned demolition of a mosque in the country’s northwest, saying that no religion is bigger than the law even as thousands of ethnic Hui Muslims continued sit-in protests against the plan. Thousands of protesters thwarted attempts by officials in Wuzhong city on Thursday to demolish parts of the Weizhou Grand Mosque in Ningxia Hui Autonomous Region for alleged violations during its recent renovation. The sit-in reportedly continued towards the weekend as the protesters stayed put in the mosque. They refused to leave and the appearance of large cooking stoves and large supplies of food and water last evening suggested many of them were in for the long haul, the Hong Kong-based South China Morning Post reported.

“The officials have not given us a clear answer. And we plan to carry on until the government makes it clear that it won’t make any changes to the mosque,” the Post quoted a protester as saying.

Chinese officials say the mosque authorities which carried out a renovation in 2015 made it look like a typical mosque from the Middle East and they want its “Arab style” domes to be replaced with Chinese style “pagodas”. This was deemed unacceptable by most members of the community.

“After taking down the domes, the mosque can no longer be an icon of Islam,” said a local man who declined to give his name. “Changing it to a traditional Chinese style is as incongruous as putting the mouth of a horse on the head of an ox,” he told the Post.

While there was no official reaction yet to the act of defiance by the Hui Muslim community, which unlike the Uygur Muslims from Xinjiang province, has a peaceful reputation, state media said no religion can be above the law.

“Chinese people enjoy religious freedom protected by the Constitution of China, the country under the leadership of the Communist Party of China (CPC). No religion shall have the privilege over laws and regulations of the country,” an op-ed in state-run Global Times said today.

“All religious activities should abide by the country’s laws and all religions shall be treated equally,” it said, adding that “to effectively solve the issue, local authorities need to stick to the law and take local people’s feelings and interests into consideration,” it said.

Blaming local officials for allowing the construction, the report said “they need to admit their mistakes and inform the area’s Muslims why it is necessary to take corrective actions in regard to the illegality of the ungranted (unapproved) expansion”.

“When an issue such as this does arise, it is important for Chinese citizens to uphold the authority of the government’s laws and to achieve unity in society. They should also be vigilant against the intervention of foreign forces,” it said.

According to an official white paper released in April, China has about 20 million Muslims with Uygurs and Hui Muslims making up about 10 million each.

China is currently carrying out a massive crackdown against the militant East Turkestan Islamic Movement (ETIM) in the volatile Xinjiang province where the majority Uyghurs are restive over increasing settlements of Han Chinese. Compared to Uygurs who are of Turkic origin with ethnic ties to Turkey, Hui Muslims are ethnically Chinese in origin. Most of them speak Mandarin, and apart from the white caps and headscarves worn by the more traditional members of the ethnic group, they are indistinguishable from the majority Han Chinese.

Comments

ABDUL AZIZ SHE…
 - 
Sunday, 12 Aug 2018

ALLAHU AKBAR

 

HasbunAllahu wa nimal wakeel nimal maula nimal naseer

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 18,2020

British lawmaker Debbie Abrahams' e-Business visa was revoked as she was involved in anti-India activities and the cancellation was conveyed to her on February 14, government sources said on Tuesday.

Asserting that the grant, rejection or revocation of a visa or electronic travel authorisation is the sovereign right of a country, the sources said Abrahams was issued an e-Business visa on October 7 last year which was valid till October 5, 2020 for attending business meetings.

"Her e-Business visa was revoked on February 14, 2020 on account of her indulging in activities which went against India's national interest. The rejection of the e-Business visa was intimated to her on February 14," a source said.

Abrahams, who chairs a British parliamentary group on Kashmir, was denied entry into India upon her arrival at the New Delhi airport on Monday.

Government officials had said on Monday also that she was informed in advance that her e-visa had been cancelled.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 22,2020

London, Apr 22: The UK government on Tuesday announced a 20 million pounds funding for a University of Oxford project working on developing a vaccine against the novel coronavirus, which is now ready for acceleration as it begins human trials from Thursday.

UK Health Secretary Matt Hancock told the daily Downing Street briefing that the Department for Health was “throwing everything” at trying to find a vaccine because it is a critical aspect of the COVID-19 pandemic fight and lifting the strict lockdown measures in place to curb its spread.

Another 22.5 million pounds is being made available to Imperial College London to support its phase-two clinical trials for them to begin the work on a very large phase three trial.

"Normally it would take years to get to this point," said Hancock.

"The UK is at the forefront of the global effort – we've put in more money than any other into the global search for a vaccine. Nothing about this is inevitable. Vaccine production is a matter of trial and error. But the UK will throw everything it has at trying to find one,” he said.

The announcement came as Britain had another major daily leap in the hospital death toll from coronavirus, up by 823 to hit 17,337 on Tuesday.

But the Cabinet minister said the government's plan to control the rapid spread of the virus and prevent the state-funded National Health Service (NHS) from being overwhelmed is working as the number of hospitalisations with COVID-19 was showing a downward trajectory.

In reference to a major issue in the last few weeks of a critical shortage of personal protective equipment (PPE) for doctors and nurses on the frontlines of COVID-19 treatment, the minister said the supply problems are being addressed by actively engaging with thousands of companies, including 159 UK manufacturers.

“We are determined to get people the PPE they need. This is a 24/7 operation, one of the biggest cross-government operation I have ever seen," said Hancock.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.